HomeFBLG • NASDAQ
add
Fibrobiologics Inc
Previous close
$1.29
Day range
$1.16 - $1.33
Year range
$0.76 - $13.59
Market cap
46.68M USD
Avg Volume
202.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.71M | 49.68% |
Net income | -3.10M | 68.11% |
Net profit margin | — | — |
Earnings per share | -0.09 | — |
EBITDA | -3.66M | -49.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.98M | 52.62% |
Total assets | 16.44M | 39.12% |
Total liabilities | 13.71M | 29.73% |
Total equity | 2.74M | — |
Shares outstanding | 37.74M | — |
Price to book | 16.12 | — |
Return on assets | -68.96% | — |
Return on capital | -105.53% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.10M | 68.11% |
Cash from operations | -3.07M | -91.94% |
Cash from investing | -99.00K | -4,850.00% |
Cash from financing | 9.33M | — |
Net change in cash | 6.16M | 484.15% |
Free cash flow | -4.61M | -164.88% |
About
Founded
2021
Headquarters
Website
Employees
13
